| __timestamp | Dr. Reddy's Laboratories Limited | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 59644696 |
| Thursday, January 1, 2015 | 42585000000 | 79541000 |
| Friday, January 1, 2016 | 45702000000 | 98015000 |
| Sunday, January 1, 2017 | 46372000000 | 103958000 |
| Monday, January 1, 2018 | 46910000000 | 103654000 |
| Tuesday, January 1, 2019 | 48890000000 | 128951000 |
| Wednesday, January 1, 2020 | 50129000000 | 135799000 |
| Friday, January 1, 2021 | 54559000000 | 149883000 |
| Saturday, January 1, 2022 | 62081000000 | 220206000 |
| Sunday, January 1, 2023 | 105931000000 | 265542000 |
| Monday, January 1, 2024 | 77201000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, understanding the financial strategies of key players is crucial. Dr. Reddy's Laboratories Limited and Travere Therapeutics, Inc. offer a fascinating study in contrasts. Over the past decade, Dr. Reddy's has seen a steady increase in its Selling, General, and Administrative (SG&A) expenses, peaking in 2023 with a staggering 105% increase from 2014. This growth reflects their aggressive expansion and market penetration strategies.
Conversely, Travere Therapeutics, Inc. has maintained a more conservative trajectory, with SG&A expenses growing by approximately 345% over the same period. This indicates a more cautious approach, likely focusing on niche markets and targeted innovations. Notably, data for 2024 is incomplete, suggesting potential shifts in strategy or reporting. As these companies navigate the complexities of the global market, their financial decisions will continue to shape their competitive edge.
Novo Nordisk A/S and Travere Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Dr. Reddy's Laboratories Limited
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? Insmed Incorporated or Travere Therapeutics, Inc.
Dr. Reddy's Laboratories Limited and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Exelixis, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc. Trends and Insights
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Galapagos NV
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Amphastar Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. and Travere Therapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Axsome Therapeutics, Inc. or Travere Therapeutics, Inc.